Yamina Belabassi, Ph.D., is a technical advisor with SPARK IP Law. Her doctoral and postdoctoral training and multidisciplinary engineering background provide extensive research experience and knowledge in a wide range of areas including technological advice in support of validity, infringement, and patentability analysis in chemistry, bio-organic systems, medicinal chemistry, nanotechnology, biochemistry and pharmacology.
Prior to joining the firm, Dr. Belabassi was a consultant at ATERIS Technologies, LLC. Additionally, Dr. Belabassi was a research professional at The Department of Biomedical and Pharmaceutical Sciences at the University of Montana where she focused her research at developing new biosensors capable of detecting biomarkers that result from a covalent modification of cholinesterases and related proteins with reactive chemical agents and dedicated to the synthesis and production of neurotransmitter-based small molecule ligands, probes, and bioconjugates. With her team, she was the first scientist internationally to develop radiotracer for organophosphate poisoning for PET-imaging. She was also involved in the design and synthesis of novel vesicular glutamate transporter inhibitors. At The Institute of Molecular Chemistry of Reims (France), her research interests focused on designing novel nanohydrogel as Gadolinium contrast agents based nanoparticles for Magnetic Resonance Imaging. Dr. Belabassi received her Ph.D. in Organic Chemistry from Texas Christian University, a M.Sc. in Chemistry of Biomolecules from The University of Science of Montpellier (France), a M. Eng. in chemical engineering from École Nationale Supérieure de Chimie de Montpellier (France), and a B. Sc. in Biochemistry from The University of Science of Montpellier (France). Her graduate and postdoctoral training provided her with extensive research experience and knowledge in different field of chemistry and has conducted 14 international presentations. Dr. Belabassi has authored several peer-reviewed articles in the fields of organic, medicinal and polymer chemistry research and is fluent in French, English, Spanish and Arabic.